Timing Cancer Treatment
1,782 views · Published 13 March 2016 · 3:23 · Indexed 8 November 2026
Channel: Harvard University · 2016 · Education
There may be an ideal waiting period for delivering multiple cancer drugs Researchers led by members of the Department of Systems Biology at Harvard Medical School had been studying how silencing MDMX, an oncogene, affected the dynamics of p53, a natural tumor suppressor, in cancer cells when they realized those dynamics might affect the cells’ sensitivity to a second, chemotherapy-like treatment. Learn more at https://hms.harvard.edu/news/timing-matters
More from this channel
-
2:30
Harvard serves
-
3:11
Lesotho: New hospital confronts deadly XDR-TB
-
5:09
Lesotho: Harvard doc delivers mountain healthcare
-
6:09
Building computers that "see" and understand
-
17:53
Advancing Scholars
-
2:56
First-Year Outdoor Program
-
55:06
An Introduction to the Dataverse Network as an Infrastructure for Data Sharing
-
1:08:40
Energy Innovation at Scale with Steven Koonin